US authorizes monkeypox vaccine injection method to increase supply

The U.S. drug regulator on Tuesday authorized Bavarian Nordic’s Jynneos vaccine for emergency use through intradermal injection for adults at high risk of monkeypox infection to increase supply to combat the outbreak.

The authorization from the Food and Drug Administration (FDA) will increase the total number of doses available for use by up to five-fold.

The regulator’s authorization comes after the United States as well as the World Health Organization declared monkeypox a public health emergency to bolster the response against the outbreak.

“In recent weeks the monkeypox virus has continued to spread at a rate that has made it clear our current vaccine supply will not mee…

Keep on reading: US authorizes monkeypox vaccine injection method to increase supply